Ftse Mib
34.165,92
0,01%
DAX
19.909,14
-0,25%
S&P 500
5.927,48
-0,73%
NASDAQ
19.546,25
-0,89%
Bitcoin
92.323,01
-1,28%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Intellia Therapeutics Inc (NTLA) Intellia Therapeutics Inc (NTLA) Notizie

Intellia Therapeutics Inc

NTLA
11,515
-0,455 (-3,80%)
Ultimo aggiornamento: 18:13:06
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
03/12/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
25/11/202413:30GLOBEIntellia Therapeutics Announces FDA Regenerative Medicine..
18/11/202413:00EDGAR2Form 8-K - Current report
16/11/202416:16GLOBEIntellia Announces First Clinical Evidence from Ongoing..
07/11/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:45EDGAR2Form 8-K - Current report
07/11/202413:30GLOBEIntellia Therapeutics Announces Third Quarter 2024 Financial..
05/11/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
31/10/202412:30GLOBEIntellia Therapeutics Announces Two Upcoming Investor..
25/10/202422:59EDGAR2Form 8-K - Current report
24/10/202414:01GLOBEIntellia Presents Positive Results from the Phase 2 Study of..
10/10/202413:30GLOBEIntellia Therapeutics Announces New Date for Upcoming..
07/10/202413:30GLOBEIntellia Therapeutics Announces Initiation of HAELO Phase 3..
04/10/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
01/10/202413:30GLOBEIntellia Therapeutics to Present New Clinical Data from the..
12/9/202413:30GLOBEIntellia Therapeutics to Present Data from the Phase 2 Study..
03/9/202422:30GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
08/8/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:45EDGAR2Form 8-K - Current report
08/8/202413:30GLOBEIntellia Therapeutics Announces Second Quarter 2024..
01/8/202413:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
30/7/202413:30GLOBEIntellia Therapeutics Receives Authorization to Initiate..
24/7/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202422:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/7/202422:01GLOBEIntellia Therapeutics Reports Inducement Grants under Nasdaq..
18/7/202422:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/7/202418:53PRNUSKuehn Law Encourages Investors of Intellia Therapeutics,..
26/6/202413:30GLOBEIntellia Therapeutics Announces CFO Transition
25/6/202421:30GLOBEIntellia Announces Positive Clinical Proof-of-Concept Data..
17/6/202413:30GLOBEIntellia Therapeutics to Present the First-Ever Clinical..
14/6/202422:24EDGAR2Form 8-K - Current report
14/6/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202413:30GLOBEIntellia Therapeutics Names Brian Goff to its Board of..
13/6/202422:59EDGAR2Form 8-K - Current report
02/6/202414:00GLOBEIntellia Therapeutics Announces Positive Long-Term Data from..
09/5/202422:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:40EDGAR2Form 8-K - Current report
09/5/202413:30GLOBEIntellia Therapeutics Announces First Quarter 2024 Financial..
02/5/202413:30GLOBEIntellia Therapeutics to Hold Conference Call to Discuss..
29/4/202413:30GLOBEIntellia Therapeutics to Present Updated Data from Phase 1/2..
18/3/202412:30GLOBEIntellia Therapeutics Announces First Patient Dosed in the..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202413:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 11,80 Min: 11,40 Max: 11,85
Chiusura: 11,97

La tua Cronologia

NASDAQ
NTLA
Intellia Therapeutics
LSE
SMV
Smoove
BIT
SGFM
Graniteshares 1x Short G...
BIT
NSCIT59058F0
International Bank for R...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network